Cellosaurus logo
expasy logo

Cellosaurus YPK-1 (CVCL_CZ89)

[Text version]
Cell line name YPK-1
Accession CVCL_CZ89
Resource Identification Initiative To cite this cell line use: YPK-1 (RRID:CVCL_CZ89)
Comments Population: Japanese.
Doubling time: 49.3 hours (CelloPub=CLPUB00333).
Omics: Transcriptomics; Microarray.
Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
HLA typing Source: PubMed=18575732
Class I
HLA-AA*02,24
HLA-BB*01,46
HLA-CC*03
Disease Pancreatic adenocarcinoma (NCIt: C8294)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Male
Age at sampling 62Y
Category Cancer cell line
Publications

CLPUB00333
Yamamoto K., Yahara N., Gondo T., Ishihara T., Oka M.
Establishment and characterization of a new human pancreatic cancer cell Line, YPK-1.
Bull. Yamaguchi Med. Sch. 49:33-42(2002)

PubMed=17089051; DOI=10.3892/or.16.6.1285
Toshimitsu H., Iizuka N., Yamamoto K., Kawauchi S., Oga A., Furuya T., Oka M., Sasaki K.
Molecular features linked to the growth-inhibitory effects of gemcitabine on human pancreatic cancer cells.
Oncol. Rep. 16:1285-1291(2006)

PubMed=18575732; DOI=10.3892/or.20.1.155
Kawaoka T., Oka M., Takashima M., Ueno T., Yamamoto K., Yahara N., Yoshino S., Hazama S.
Adoptive immunotherapy for pancreatic cancer: cytotoxic T lymphocytes stimulated by the MUC1-expressing human pancreatic cancer cell line YPK-1.
Oncol. Rep. 20:155-163(2008)

Cross-references
Encyclopedic resources Wikidata; Q54995478
Entry history
Entry creation13-Jul-2016
Last entry update10-Apr-2025
Version number9